$QSAM Biosciences Announces FDA Clearance of IND for Samarium-153 DOTMP (CycloSam®), an Investigational Radiopharmaceutical for the Treatment of Bone Cancer
#UnderValued #otcmarkets #nasdaq #investors https://www.otcmarkets.com/stock/QSAM/news/QS...?id=317971